In:
Infection Control & Hospital Epidemiology, Cambridge University Press (CUP), Vol. 44, No. 1 ( 2023-01), p. 114-117
Abstract:
Real-world studies have demonstrated impressive effectiveness of the BNT162b2 COVID-19 vaccine in preventing symptomatic and asymptomatic SARS-CoV-2 infection. We describe an outbreak of SARS-CoV-2 infections in a hospital with high vaccine uptake. We found a low secondary attack rate (7%), suggesting low infectivity of vaccinated persons with vaccine breakthrough SARS-CoV-2 infections.
Type of Medium:
Online Resource
ISSN:
0899-823X
,
1559-6834
DOI:
10.1017/ice.2021.412
Language:
English
Publisher:
Cambridge University Press (CUP)
Publication Date:
2023
detail.hit.zdb_id:
2106319-9
Permalink